Brief: RepliCel Life Sciences appoints Lee Buckler as CEO effective Jan. 1 2016
16/12/2015 14:01
Dec 16 (Reuters) - RepliCel Life Sciences Inc RP.V : * Announces leadership transition * Appointed Lee Buckler as company's new chief executive officer and president, effective January 1, 2016 * Says CEO David Hall to retire * Source text for Eikon ID:nMKW1jtk2a * Further company coverage RP.V ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Replicel Life Sciences
See all newsBrief: Replicel Life Sciences Announces Reinstatement Of Trading & Conditional Acceptance For Proposed Transaction
Brief: Replicel Life Sciences Says Replicel Announces A Letter Of Intent For Asset Purchase Agreement
Brief: Replicel Announces Binding Term Sheet For Strategic Investment And U.S. Partnership
Brief: Replicel Announces Its Incoming Board Of Directors
Brief: RepliCel Life Sciences Retains Dermatology Sales And Marketing Executive To Guide Global Commercial Strategy For Automated Dermal Injector